SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 -Dadra Facility Receives Warning Letter From US FDA

Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Mid-range Performer

1600.3000 -56.40 (-3.40%)

NSE Aug 26, 2025 15:31 PM

Near 52W Low of ₹1553.05

Volume: 4.5M

Sun Pharmaceutical Industries Ltd.

19 Jun 2024

1600.30

-3.40%

Company Update

SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And …

BSE India

Intimation regarding Warning Letter from US FDA

More from Sun Pharmaceutical Industries Ltd.

Recommended

Market closes lower, Minister of State for Communications denies relief for Vodafone Idea

Trendlyne Marketwatch | 26 Aug 2025, 04:06PM

IPO activity surges with ten new issues and ten listings this week

Change is hard, and some Indian pharma companies are embracing it better than others